11:56am ET
Health and Healthcare
Big Pharma Matchup: Valeant vs Gilead
Here are two big biopharmas, both with multibillion dollar portfolios and both of which have lost a combined $113 billion in market cap since August.
Companies
Valeant Pharmaceuticals Intern...
$23.40
▼ $0.83 (−3.43%) today
Markets closed · 5:26pm ET
VRX Coverage
Page 9
6:48am ET
Special Report
CEOs Who Have to Go in 2016
Shareholders put their trust in the chief executive officer to direct the company to better fortunes. At some point, however, a CEO can do more harm than good. The telltale signs the…
11:40am ET
Health and Healthcare
Valeant CEO Takes Temporary Leave on Health Scare
Valeant Pharmaceuticals watched its shares move lower in Monday’s trading session on a health scare from one of its top executives.
Chris Lange 7:10am ET
Health and Healthcare
4 Top Biotech Stocks for 2016
Biotech looks set to close out 2015 as its worst performing year since 2008. But can we expect a better 2016 for this exciting sector?
10:28am ET
Investing
10 Stocks to Pick Up in December
Here are 10 stocks that could outperform the index funds from now to early February.
10:25am ET
Health and Healthcare
6 BioHealth Movers That Now Cannot Be Ignored
24/7 Wall St. examines Valeant Pharmaceuticals and other biotech stocks with incredible gains or losses over the course of the past week.
10:55am ET
Investing
Jefferies Has 4 Very Bold Value Calls This Week
All these top value picks at Jefferies have some degree of either headline risk or just headline overhang, but the upside potential is huge if the firm is correct.
9:25am ET
Health and Healthcare
5 BioPharma Movers That Cannot Be Ignored
Last week, a few biotech companies made absolutely massive runs, while others had serious falls.
4:04pm ET
Investing
The 52-Week Low Club for Thursday
November 5, 2015: Here are four stocks trading with heavy volume among 92 equities making new 52-week lows today. Qualcomm Inc. (NASDAQ: QCOM) dropped about 17% on Thursday to post a new…
10:10am ET
Health and Healthcare
6 BioPharma Movers That Cannot Be Ignored
Last week, a few biotech companies made absolutely massive runs, and some had serious falls.
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: DreamWorks, First Solar, NVIDIA, SolarCity, Valeant, YRC Worldwide and More
Friday's top analyst upgrades, downgrades and initiations include DreamWorks Animation, First Solar, NVIDIA, SolarCity, Valeant Pharmaceuticals and YRC Worldwide.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: BioDelivery, Merrimack, Silver Wheaton, Valeant, Weatherford and More
Tuesday's top analyst upgrades, downgrades and initiations include BioDelivery Sciences, Merrimack Pharmaceuticals, Silver Wheaton, Valeant Pharmaceuticals and Weatherford International.
9:40am ET
Health and Healthcare
8 BioPharma Movers That Cannot Be Ignored
These biotech stocks 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the course of the past week.
4:04pm ET
Investing
The 52-Week Low Club for Wednesday
October 21, 2015: Here are four stocks trading with heavy volume among 94 equities making new 52-week lows today. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped nearly 40% on Wednesday to post…
12:50pm ET
Investing
6 Key Analyst Downgrades From Wednesday That Cannot Be Overlooked
Several key analyst downgrades on Wednesday were too big to overlook. Some moves may seem obvious, but they may seal the fate of some stocks to have much lower upside expectations ahead.